No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
IHE240719P63330
- 0.67
- 0.000.00%
15min DelayClose Jul 3 12:57 ET
0.00High0.00Low
0.67Open0.67Pre Close0 Volume0 Open Interest63.33Strike Price0.00Turnover30.55%IV4.50%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier14DDays to Expiry0.67Extrinsic Value100Contract SizeAmericanOptions Type-0.2633Delta0.0805Gamma97.93Leverage Ratio-0.0424Theta-0.0066Rho-25.78Eff Leverage0.0434Vega
Intraday
- 5D
- Daily
News
IShares U.S. Pharmaceuticals ETF Declares Quarterly Distribution of $0.2940
Health Care Is Still Very Crowded but Trades at a Discount Vs. History - BofA
The health care sector (NYSEARCA:XLV) is crowded despite a reversal on the recession outlook, according to BofA Securities’ Sector Focus Point report.
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
As April comes to a close, it's time to compile the rankings for the top-performing sector and industry exchange-traded funds of the month.Taking a broader look at the stock market, the S&P 500 Index,
Cons Disc Distribution & Retail Has the Highest Dispersion Among S&P Groups - MS
IShares U.S. Pharmaceuticals ETF Declares Quarterly Distribution of $0.2750
Ishares Trust U.S. Pharmaceuticals Etf To Carry Out 3-for-1 Stock Split On March 7th, 2024
December 22nd - $Ishares Trust U.S. Pharmaceuticals Etf(IHE.US)$ is about to implement a 3-for-1 stock split of shares. The shares will begin trading on a split-adjusted basis from March 7th, 2024.$Is
Comments
1
Which fund investment themes are you bullish on? Do you have any specific fund(s) in mind?
Are you looking at a specific industry/market/asset type? Why?
What is your latest fund investment plan? What are the reasons behind it?
The current macro conditions (high inflation, FED rate hike and recession) have crippled our will to invest in long term. In my previous post, I reveal plan to invest in long term to position myself when the economy recover hopefully by ...
Are you looking at a specific industry/market/asset type? Why?
What is your latest fund investment plan? What are the reasons behind it?
The current macro conditions (high inflation, FED rate hike and recession) have crippled our will to invest in long term. In my previous post, I reveal plan to invest in long term to position myself when the economy recover hopefully by ...
11
10
Announcement Document
$AbbVie(ABBV.US$: AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
$Protagonist Therapeutics(PTGX.US$: Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis
$PTC Therapeutics(PTCT.US$: Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022
$Scholar Rock(SRRK.US$: Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Follow for more insights and top news for pharmacy industry!![]()
![]()
$The Health Care Select Sector SPDR® Fund(XLV.US$ $Spdr Series Trust Spdr S&P Pharmaceuticals Etf(XPH.US$ $Ishares Trust U.S. Pharmaceuticals Etf(IHE.US$
$AbbVie(ABBV.US$: AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
$Protagonist Therapeutics(PTGX.US$: Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis
$PTC Therapeutics(PTCT.US$: Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022
$Scholar Rock(SRRK.US$: Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Follow for more insights and top news for pharmacy industry!
15
1
Read more